baber/WOPTO huggingface dataset:
Patent NZ-529369-A (NZ)
Title: Insecticidal seed coating for improving crop performance
Inventor: CHEN YUGUANG
IPC: A01N25/10
Filed: 1998-12-14
Abstract: An insecticidal coating for a seed comprising one or more binders selected from the group consisting of polymers and copolymers of polyvinyl acetate, methyl cellulose, polyvinyl alcohol, vinylidene chloride, acrylic, cellulose, polyvinylpyrrolidone and polysaccharide and an insecticide and filler wherein the binder forms a matrix for the insecticide and filler resulting in a substantially non-phytotoxic seed coating is disclosed. Methods for producing the coating and the seed treated with this coating and a method of controlling soil-borne insect pests, particularly from the order of Coleoptera, such as Diabrotica spp., comprsing applying to a seed an insecticidal coating as described above is also disclosed. (62) Divided out of 512193
Patent NZ-532174-A (NZ)
Title: Voice over synchronisation
Inventor: KITE-ROLLINSON RHONDA VIOLET M
Filed: 2004-04-06
Abstract: A computer apparatus for displaying a synchronised sound script has at least one symbol representative of a sound event. The computer apparatus comprises a means for generating a graphical user interface on a display screen. The graphical user interface has a control element associated with the at least one symbol. The control element allows adjustment of the synchronisation of the at least one symbol with an original recording. The control element is adapted to be activated by a pointing device to generate a control signal to vary a vocalisation time for the at least one symbol. The computer apparatus also comprises a means responsive to the generation of the control signal by activation of the control element to associate a new vocalisation time for the at least one symbol.
Patent NZ-540398-A (NZ)
Title: Improved motor vehicle safety barrier mounting
Inventor: GIUMELLI MARK ANTHONY
IPC: B60R21/06
Filed: 2002-12-17
Abstract: A improved form of attachment for a motor vehicle safety screen assembly which includes a screen having a perimeter frame (12) of tubular metal and an infill panel (13) extending between the perimeter frame members, and a plurality of metal securing straps (15) which are connected to the frame (12) of the screen by means of connector brackets (20) each mounted on a bush (22) which is fitted on a respective frame member of the frame (12), wherein each of the brackets (20) can be rotated about the axis of their associated bush (22) to positions on opposites sides of the screen. The bushes (22) are made of two hinged portions which can be opened to facilitate attachment to the frame member and then subsequently closed and clipped together.
Patent NZ-543523-A (NZ)
Title: Container for piece goods
Inventor: QUADRELLI SANDRO
IPC: B65D5/02
Filed: 2004-05-13
Abstract: A tubular, preferably hexagonal, container 11 (and blank) for sweets and chocolates has a hexagonal base, front 18, rear, and pairs of front side 16, 20 and rear side walls and an outlet opening 125 through which the sweets may be dispensed. The outlet opening has a lid 26 to close the outlet opening and connected to and extending from the container body. The container body has a stiffener 117 located at the outlet opening and connected and extending to at least the front side walls or rear side walls of the container body so that the container tends to retain its hexagonal shape along the container and in particular in the vicinity of the outlet opening.
Patent NZ-547597-A (NZ)
Title: Collapsible container with folding side-walls
Inventor: KUSUMA DAVID
IPC: B65D8/14
Filed: 2004-12-01
Abstract: A collapsible container (10) with angularly related multiple folding sections (34), each section (34) extending at an angle to the vertical, and flexure zones (40) between adjacent sections (34) for flexibly moving the sections between a first open position in the expanded container and a second position folded upon itself in the collapsed container, the flexure zones (40) resisting movement of the sections (34) in both the fully expanded container and the collapsed container, as well as any intermediate position wherein only selected flexure zones (40) are in an open position.
Patent NZ-548184-A (NZ)
Title: Polymeric plastics material and manufacture thereof
Inventor: NASARCZYK ANDREW
IPC: D01F6/06
Filed: 2004-12-24
Abstract: Disclosed is a polymeric multifilament fibre formed from a multitude of filaments, the fibre having a plurality of capillaries, each fibre including a polymeric composition including a mixture of a polymer, copolymer or combination thereof of propylene and a wax in an amount between 0.5 and 5% by weight of the composition; and a surface coating of an oil lubricant in an amount between 0.5 and 5% by volume of the filaments, wherein the combination of the wax and oil lubricant substantially prevents the fibre from absorbing moisture by capillary action.
Patent NZ-548351-A (NZ)
Title: Direct compression formulation and process
Inventor: KOWALSKI JAMES
IPC: A61K9/20
Filed: 2005-01-17
Abstract: Disclosed is a compressed pharmaceutical tablet of a direct compressed pharmaceutical tablet, wherein the dispersion contains particles comprising a DPP-IV inhibitor which is (S)-1[(3-hydroxy-1-adamantyl-amino]acetyl-2-cyano-pyrrolidine, in free form or in acid addition salt form, and wherein at least 60% of the particle size distribution in the tablet is less than 250 micrometers.
Patent NZ-549123-A (NZ)
Title: Display mounting system
Inventor: HOPKINS JOHN
Filed: 2006-08-09
Abstract: A system for installation of multiple panels for shelving and the like, wherein the geometry of the junction between panels (1,2) provides a cavity adapted to receive the anchoring portion (20) of shelf support brackets, or the like.
Patent NZ-550148-A (NZ)
Title: 3-'4-heterocyclyl-1,2,3,-triazol-1-yl-N-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
Inventor: COGAN DEREK
IPC: C07D403/04
Filed: 2005-03-04
Abstract: The present disclosure relates to 3-4-heterocyclyl-1-H-1,2,3-triazol-1-yl-N-aryl-benzamide derivatives of formula (I), which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease and oncological diseases. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.
Patent NZ-551017-A (NZ)
Title: Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
Inventor: KUANG RONGZE
IPC: A61K31/4709
Filed: 2005-05-16
Abstract: The disclosure relates to substituted 2-quinolyl-oxazole compounds of formula (I); wherein, the ring A is a 5-membered heteroaryl as shown in the specification; X is S or O; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions, the use of the compounds as PDE4 inhibitors, and combinations with other actives.
Patent NZ-555139-A (NZ)
Title: Corrugated slip sheet for use between layers of a palletised load
Inventor: FACEY HUGH DAVID
IPC: B65D71/70
Filed: 2005-09-21
Abstract: A slip sheet for use between layers of upright containers in a palletised load including a flat substantially rectangular board having marginal portions formed with corrugations extending perpendicularly from their edges and merging into the general plane of the board.
Patent NZ-556278-A (NZ)
Title: Bisphosphonic acid for the treatment and prevention of osteoperosis
Inventor: BAUSS FRIEDER
IPC: A61P19/08
Filed: 2003-05-02
Abstract: Disclosed is the use of a bisphosphonic acid or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the prevention or the treatment of disorders characterized by pathologically increased bone resorption, particularly for the prevention and treatment of osteoporosis, wherein the medicament is manufactured for oral administration of 100 to 150 mg bisphosphonic acid or a pharmaceutically acceptable salt thereof on one day per month, with the proviso that the bisphosphonic acid or pharmaceutically acceptable salt thereof is not ibandronic acid or a pharmaceutically acceptable salt thereof. A pharmaceutical composition for oral administration for the prevention or the treatment of disorders characterized by pathologically increased bone resorption is also disclosed, wherein the composition comprises a unit dosage amount of 100 to 150 mg bisphosphonic acid or a pharmaceutically acceptable salt thereof for administration on one day per month, with the proviso that the bisphosphonic acid or pharmaceutically acceptable salt thereof is not ibandronic acid or a pharmaceutically acceptable salt thereof.
Patent NZ-556287-A (NZ)
Title: Non-combustible reinforced cementitious lightweight panels and metal frame system for roofing
Inventor: TONYAN TIMOTHY
IPC: E04B1/00
Filed: 2006-01-13
Abstract: A non-combustible roofing system 10 for construction comprising a sloped or flat shear diaphragm supported on light gauge cold rolled metal framing 13, the shear diaphragm comprising a reinforced, lightweight, dimensionally stable structural cementitious panel 20 and the framing 13 comprising metal roofing elements, the panel 20 having a density of 65 to 90 pounds per cubic foot and capable of resisting shear loads when fastened to framing 13 and comprising a continuous phase resulting from the curing of an aqueous mixture comprising, on a dry basis, 35 to 70 weight % reactive powder, 20 to 50 weight % lightweight filler, and 5 to 20 weight % glass fibers, the continuous phase being reinforced with glass fibers and containing the lightweight filler particles, the lightweight filler particles having a particle specific gravity of from 0.02 to 1.00 and an average particle size of about 10 to 500 microns (micrometers), wherein the panel 20 is attached to the metal roofing elements by screws with winged driller located above the point and below the threads of the screw and protrude laterally from a shaft of the screw to provide a shear load bearing roofing system 10, and wherein the roofing system 10 meets the 2 hour fire resistance test rating under ASTM E-119, effective 2003.
Patent NZ-556323-A (NZ)
Title: Use of morpholino compounds for the prevention of bacterial contamination
Inventor: LANE JONATHAN
IPC: A61F2/82
Filed: 2006-02-01
Abstract: Disclosed is the use of a compound of formula (I) or a salt thereof for the prevention or reduction of biofilm formation on an abiotic surface, or to prevent or reduce viable microbial growth on an abiotic surface, such as surgical devices.
Patent NZ-563795-A (NZ)
Title: System, method and process for order and delivery of classified goods and services through an amalgamated drive-thru complex
Inventor: SAIGH MICHAEL
Filed: 2005-05-24
Abstract: A process for controlling a vehicle drive-thru or drive-up facility is provided. The process includes the steps of: - providing a structural facility to receive, store and deliver commercial and retail classified goods and serviceable items for one or more tenants within the facility, the structural facility having a centralized order processing portion and a plurality of vehicle drive-thru pick up areas attached to the centralized processing portion to receive a customer's vehicle; - introducing at least one core computer system communicatively compatible with a customer and with other computers communicating with the core computer system, the core computer system able to control, access and deliver the classified goods and serviceable items from within and outside of the facility to a customer's location, and also able to control and access the centralized order processing portion and to control the plurality of drive-thru pick up areas for potential delivery of classified goods and serviceable items to a customer and for potential acceptance of items from a customer, the core computer system further adapted to optimize traffic flow through the drive-thru pick up area. A method for managing the drive-through process is also disclosed.
Patent NZ-569071-A (NZ)
Title: Solid preparation containing an insulin sensitizer
Inventor: KIYOSHIMA KENICHIRO
IPC: A61K9/20
Filed: 2006-12-21
Abstract: Disclosed is a solid preparation comprising: a part containing coated particles containing pioglitazone and coated with lactose, and a part containing glimepiride.
Patent NZ-570413-A (NZ)
Title: Methods for the diagnosis of dementia and other neurological disorders
Inventor: COOK LISA
IPC: G16H10/40
Filed: 2007-02-28
Abstract: Disclosed is a method for diagnosing dementia or the risk of dementia in a patient, the method comprising the steps of: a) analyzing a blood sample from said patient to obtain quantifying data for one or more than one metabolite marker; b) comparing the quantifying data for said one or more than one metabolite marker to corresponding data obtained for one or more than one reference sample to identify an increase or decrease in the level of said one or more than one metabolite marker in said blood sample; and c) using said increase or decrease in the level of said one or more than one metabolite marker in said blood sample to diagnose dementia or the risk of dementia in said patient, wherein the one or more than one metabolite marker comprises one or more molecules selected from the group consisting of plasmenylethanolamine or smanylethanolamine, or combinations thereof.
Patent NZ-574673-A (NZ)
Title: Site specific incorporation of non-natural amino acids by vertebrate cells
Inventor: TIAN FENG
IPC: C12N1/21
Filed: 2007-09-07
Abstract: A vertebrate cell or cell line that comprises an orthogonal aminoacyl-tRNA synthetase (O-RS) having the amino acid sequence SEQ ID NO: 45. The O-RS is capable of preferentially aminoacylating an orthogonal tRNA (O-tRNA) comprising the transcript of the nucleotide sequence of SEQ ID NO: 88 with p-acetyl-phenylalanine (pAF) or p-amino-phenylalanine.
Patent NZ-577564-A (NZ)
Title: Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
Inventor: HELLSTROM MATS
IPC: C12N/
Filed: 2004-12-06
Abstract: Provided is an isolated specified nucleic acid molecule able to stimulate or inhibit vasculogenesis, angiogenesis and endothelial cell growth and migration. Further provided are variants and fragments of the sequences, corresponding siRNAs, polypeptides and antibodies and use of the compositions in the manufacture of medicaments for angiogenesis related disorders.
Patent NZ-583697-A (NZ)
Title: Substituted 6-phenylnicotinic acids and the use thereof
Inventor: MEIER HEINRICH
IPC: A61P9/00
Filed: 2008-08-26
Abstract: The disclosure relates to substituted 6-phenylnicotinic acid derivatives of formula (I) wherein the variables are as defined in the specification, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prophylaxis of cardiovascular diseases, in particular dyslipidaemias, arteriosclerosis and heart failure.
Patent NZ-588717-A (NZ)
Title: Improved strains of zymomonas mobilis for fermentation of biomass
Inventor: CHEN RACHEL RUIZHEN
IPC: C12N1/20
Filed: 2009-04-23
Abstract: Provided is a process for making a Zymomonas mobilis strain more tolerant to an inhibitor comprising: a) growing a Zymomonas mobilis strain in a medium substantially free of said inhibitor; b) sequentially culturing the Zymomonas mobilis strain in the presence of consecutively higher concentrations of the inhibitor; and c) isolating a mutant strain having an adaptive mutation to a higher concentration of said inhibitor without NTG mutagenesis. A strain growing in 1.6% acetic acid concentration is achievable with this method.
Patent NZ-589276-A (NZ)
Title: Combination therapies using hdac inhibitors and erlotinib (tarceva)
Inventor: LICHENSTEIN HENRI
IPC: A61K33/243
Filed: 2006-02-03
Abstract: Disclosed is the use of a histone deacetylase inhibitor in the manufacture of a medicament for the treatment of cancer, wherein said treatment comprises treatment with: (i) said histone deacetylase inhibitor; and (ii) Tarceva (erlotinib or N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine); wherein the histone deacetylase inhibitor is a compound of formula (I) (also known as (2E)-3-[3-(anilinosulfonyl)phenyl]-N-hydroxyacrylamide, Belinostat or PXD101) , or a pharmaceutically acceptable salt or solvate thereof. Cancers include leukaemia, lymphoma, cutaneous T-cell lymphoma (CTCL), noncutaneous peripheral T-cell lymphoma, a lymphoma associated with human T-cell lymphotropic virus (HTLV), adult T-cell leukemia/lymphoma (ATLL), acute lymphocytic leukemia, acute nonlymphocytic leukemias, chronic lymphocytic leukemia, chronic myelogenous leukemia, Hodgkin's Disease, non-Hodgkin's lymphoma, or multiple myeloma lung cancer and epithelial ovarian cancer.
Patent NZ-593054-A (NZ)
Title: A plastic strap handle for a container with a lid, that the ends are twisted through slots and straightened to lock into position
Inventor: LEEMING ROBERT BRIAN
IPC: B65D71/00
Filed: 2012-05-21
Abstract: An elongate strap handle 1 of resilient plastics material for a container 2. The container in particular would be a thin walled plastics container 2 with or without a cover. Both the container and the cover incorporate a pair of spaced apart strap handle mounting apertures 4 with the mounting apertures in the container and the cover aligning with one another. The strap handle has strap handle mounting aperture engaging sections at each end. Each strap handle mounting aperture engaging section includes a reduced width section forming a neck 5 with a head outwardly thereof but set in from the associated end of the strap handle. The end sections of the strap handle outwardly of the heads 6 form tongues, the inner sections 7a of which are also of a reduced width with the outer sections not being of reduced width and forming feet 8. Each head is adapted to have a transverse fold formed thereacross whereby with folding and twisting the heads can be inserted through the container mounting apertures with the neck and tongues extending back therethrough. With reverse twisting the heads can be located to abut up against the underside of the container material defining the strap handle mounting apertures with the necks and tongues impinging onto and overlapping the inner and outer ends respectively of the container apertures. In the latter case the strap handle also acts to retain the cover to the container.
Patent NZ-594154-A (NZ)
Title: Transdermal administration of buprenorphine for preoperative treatment of post operative pain
Inventor: REIDENBERG BRUCE E
IPC: A61K31/4355
Filed: 2004-07-26
Abstract: Use of buprenorphine for the manufacture of a transdermal dosage form for treating postoperative pain in a patient in need of such treatment is disclosed, wherein the treatment comprises administering to said patient said buprenorphine-containing transdermal dosage form prior to surgery; wherein the treatment may further comprise extended subsequent dosing periods with subsequent dosage forms for a given time period as needed by the patient to achieve desired analgesia; andwherein the treatment may further comprise a rapid dose escalation of buprenorphine patches to achieve the desired preoperative dosage level, wherein the treatment involves: (a) administering to the patient a first buprenorphine-containing transdermal dosage form for a first dosing period that is no longer than 5 days; (b) administering to the patient a second buprenorphine-containing transdermal dosage form for a second dosing period that is no longer than 5 days, wherein the second dosage form comprises the same dosage of buprenorphine as, or a greater dosage of buprenorphine than, the first dosage form; and (c) administering to the patient a third buprenorphine-containing transdermal dosage form for a third dosing period, wherein the third dosage form comprises a greater dosage of buprenorphine than the second dosage form, and the third dosage form is the desired dosage level for the postoperative pain control.
Patent NZ-597784-A (NZ)
Title: Changing identifier of a metering device to allow it to communicate with a different metering network such as a system under test
IPC: G01D4/02
Filed: 2012-01-24
Abstract: 597784 Disclosed is a metering communication device (116) for communicating with a plurality of metering networks (112). The device (116) includes a transceiver, a memory (312) and a processor (305). The transceiver is configured to transmit an active utility identifier to a plurality of metering networks (112). The memory (312) is configured to store the active utility identifier for communicating in an active metering network of the plurality of metering networks (112). The memory (312) is further configured to store one or more valid utility identifiers in a utility configuration table for communicating in a second metering network of the plurality of metering networks (112). The processor (305) is configured to change the active utility identifier of the metering communication device (116) to a valid utility identifier of the one or more valid utility identifiers associated with the metering communication device (116). This enables the metering communication device (116) to communicate with the second metering network of the plurality of metering networks (112).
Patent NZ-598605-A (NZ)
Title: Vaccine against african horse sickness virus
Inventor: MINKE JULES MAARTEN
IPC: A61K39/00
Filed: 2009-10-22
Abstract: 598605 Disclosed is an immunogenic composition comprising a recombinant avipoxvirus wherein the recombinant avipoxvirus comprises at least one nucleic acid molecule encoding polypeptide African Horse Sickness Virus (AHSV) VP2, wherein the composition does not comprise a nucleic acid molecule encoding a Bluetongue Virus (BTV) antigen; and wherein the composition is capable of eliciting a protective immune response in an equine animal. Further disclosed is an immunogenic composition consisting of a recombinant avipoxvirus wherein the recombinant avipoxvirus comprises at least one nucleic acid molecule encoding polypeptide African Horse Sickness Virus (AHSV) VP2. Further disclosed is an expression vector comprising a polynucleotide comprising the sequence as set forth in SEQ ID NO:4.
Patent NZ-606892-A (NZ)
Title: Synergistic fungicidal composition
Inventor: SHEFFER NOAM
IPC: A01N59/26
Filed: 2010-08-26
Abstract: The disclosure relates a fungicidal composition comprising dimethomorph, folpet and an organophosphorus fungicide selected from fosetyl and salts thereof. This disclosure also relates to a method of controlling diseases caused by phytopathogenic fungi. The fungi may be of the class Ascomycetes, Basidiomycetes, Deuteromycetes or Oomycetes or combination thereof.